Pneumococcal conjugate vaccine implementation in middle-income countries

Pneumococcal conjugate vaccine implementation in middle-income countries

Since 2000, the widespread adoption of pneumococcal conjugate vaccines (PCVs) has had a major impact in the prevention of pneumonia. Limited access to international financial support means some middle-income countries (MICs) are trailing in the widespread use of PCVs. We review the status of PCV imp...

Full description

Bibliographic Details
Main Authors: Tricarico, Serena, McNeil, Hannah C., Cleary, David W., Head, Michael G., Lim, Victor, Kok, Ivan Seng Yap, Chong, Chun Wie, Cheng, Siang Tan, Mohd Nor, Norazmi, Ismail, Aziah, Seong, Eddy Guan Cheah, Faust, Saul N., Jefferies, Johanna M.C., Roderick, Paul J., Moore, Michael, Ho, Ming Yuen, Newell, Marie-Louise, McGrath, Nuala, Doncaster, C. Patrick, Kraaijeveld, Alex R., Webb , Jeremy S., Clarke, Stuart C.
Format: Article
Language:English
Published: BioMed Central 2017
Subjects:
RA0421 Public health. Hygiene. Preventive Medicine
RS1-441 Pharmacy and materia medica
Online Access:http://eprints.usm.my/37255/1/s41479-017-0030-5.pdf
Description
Summary:Since 2000, the widespread adoption of pneumococcal conjugate vaccines (PCVs) has had a major impact in the prevention of pneumonia. Limited access to international financial support means some middle-income countries (MICs) are trailing in the widespread use of PCVs. We review the status of PCV implementation, and discuss any needs and gaps related to low levels of PCV implementation in MICs, with analysis of possible solutions to strengthen the PCV implementation process in MICs.

Similar Items